Gene expression analysis underscores the multifaceted role of GPR17 activation in the modulation of vital genes in several pathways, such as MAPK/ERK, PI3K–Akt, STAT, and NF-kB, controlling GBM disease progression. The gene discussed is SOAT1; the disease is glioblastoma.